Skip to main content
SpringerLink
Log in

Global COVID-19 vaccine study confirms safety signals

  • Clinical study
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Reference

  • Faksova K, et al. COVID-19 vaccines and adverse events of special interest: A multinational Global Vaccine Data Network (GVDN) cohort study of 99 million vaccinated individuals Vaccine : 12 Feb 2024. Available from: URL: https://doi.org/10.1016/j.vaccine.2024.01.100

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Global COVID-19 vaccine study confirms safety signals. Reactions Weekly 1996, 7 (2024). https://doi.org/10.1007/s40278-024-53460-3

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40278-024-53460-3

Search

Navigation